בייאטה 5 מק"ג

Ülke: İsrail

Dil: İbranice

Kaynak: Ministry of Health

Aktif bileşen:

EXENATIDE 250 MCG/ML

Mevcut itibaren:

ASTRA ZENECA ISRAEL LTD

ATC kodu:

A10BX04

Farmasötik formu:

SOLUTION FOR INJECTION

Uygulama yolu:

S.C

Tarafından üretildi:

LILLY PHARMA FERT. & DISTRIB. GmbH & Co. KG

Terapötik grubu:

EXENATIDE

Terapötik endikasyonlar:

Byetta is indicated as an adjunct to diet and exercise to improve glycimic control in adults with type 2 diabetes mellitus.Byetta is indicated as adjunctive therapy to improve glycemic control in patients with type 2 diabetes mellitus who are taking metformin or a sulfonylurea , alone or in combination, but have not achieved adequate glycemic control.

Yetkilendirme tarihi:

2013-01-01